Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Thoughts on Amazon –What Does Its Valuation Tells Us?

Netflix & Amazon Expand in Korea – Not a Coincidence

Okja: The Fight Between Netflix Vs. CJ CGV

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Bank of Guizhou Co Ltd / Equity Capital Markets

<p>Bank of Guizhou, the only provincial-level city commercial bank in the Guizhou province in China, is targeting to raise up to USD 900 million in its Hong Kong listing. </p>
<p>In this insight, we will cover the fundamentals of the bank. In particular, we highlight that its superior operating metrics were a result of its exposure to government affiliates and the company is mainly held by local government and corporates. </p>

Bank of Guizhou, the only provincial-level city commercial bank in the Guizhou province in China, is targeting to raise up to USD 900 million in its Hong Kong listing. 
In this insight, we will cover the fundamentals of the bank. In particular, we highlight that its superior operating metrics were a result of its exposure to government affiliates and the company is mainly held by local government and corporates. 

Bank of Guizhou (贵州银行) IPO: A Local SOE Bank Serving Local Government Affiliates